United States 118th Congress ✓ Enacted · P.L. 118-189 1 R cosponsors

S 223 — A bill to amend the Controlled Substances Act to fix a technical error in the definitions.

Last action — Became Public Law No: 118-189.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced February 01, 2023. Enacted.

Prognosis

Advancing 52% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (1 R).

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

19 added · 20 removed

Plain-language change summary

The text of the bill has been updated to include a note indicating that it was approved on December 23, 2024. Additionally, two references to the legislative history, such as the House report number and details about its consideration and passage, were removed. This change clarifies the approval date while removing earlier procedural details that may no longer be relevant.

→
Previous
Latest
[Congressional Bills 118th Congress] [From the U.S.
[118th Congress Public Law 189] [From the U.S.
Government Publishing Office] [S.
Government Publishing Office] [[Page 138 STAT.
223 Referred in House (RFH)] <DOC> 118th CONGRESS 1st Session S.
2652]] Public Law 118-189 118th Congress An Act To amend the Controlled Substances Act to fix a technical error in the definitions.
223 _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 6, 2023 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ AN ACT To amend the Controlled Substances Act to fix a technical error in the definitions.
<<NOTE:
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1.
Dec.
23, 2024 - [S.
223]>> Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1.
Passed the Senate February 1, 2023.
Approved December 23, 2024.
Attest:
LEGISLATIVE HISTORY--S.
SONCERIA ANN BERRY, Secretary.
223 (H.R.
455):
--------------------------------------------------------------------------- HOUSE REPORTS:
No.
118-681, Pt.
1 (Comm.
on Energy and Commerce) accompanying H.R.
455.
CONGRESSIONAL RECORD:
Vol.
169 (2023):
Feb.
1, considered and passed Senate.
Vol.
170 (2024):
Dec.
16, considered and passed House.
<all>
View plain text versions (5)

Sections of law this bill changes

1 section in 1 law

From the bill's own amending language, matched to the official United States Code (current through Public Law 119-121).

Drug abuse prevention and control · 21 U.S.C. ch. 13 1 section
  • § 802 Definitions Amends

    21 U.S.C. § 802

    The law today

    As used in this subchapter: (1) The term “addict” means any individual who habitually uses any narcotic drug so as to endanger the public morals, health, safety, or welfare, or who is so far addicted to the use of narcotic drugs as to have lost the power of self-control with reference to his addiction. (2) The term “administer” refers to the direct application of a controlled substance to the body of a patient or research subject by— (A) a practitioner (or, in his presence, by his authorized agent), or (B) the patient or research subject at the direction and in the presence of the practitioner, whether such application be by injection, inhalation, ingestion, or any other means. (3) The term “agent” means an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser; except that such term does not include a common or contract carrier, public warehouseman, or employee of the carrier or warehouseman, when acting in the usual and lawful course of the carrier’s or warehouseman’s business. (4) The term “Drug Enforcement Administration” means the Drug Enforcement Administration in the Department of Justice. (5) The term “control” means to add a drug or other substance, or immediate precursor, to a schedule under part B of this subchapter, whether by transfer from another schedule or otherwise. (6) The term “controlled substance” means a drug or other substance, or immediate precursor, included in schedule I, II, III, IV, or V of part B of this subchapter. The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are defined or used in subtitle E of the Internal Revenue Code of 1986. (7) The term “counterfeit substance” means a controlled substance which, or the container or labeling of which, without authorization, bears the trademark, trade name, or other identifying mark, imprint, number, or device, or any likeness thereof, of a manufacturer, distributor, or dispenser other than the person or persons who in fact manufactured, distributed, or dispensed such substance and which thereby falsely purports or is represented to be the product of, or to have been distributed by, such other manufacturer, distributor, or dispenser. (8) The terms “deliver” or “delivery” mean the actual, constructive, or attempted transfer of a controlled substance or a listed chemical, whether or not there exists an agency relationship. (9) The term “depressant or stimulant substance” means— (A) a drug which contains any quantity of barbituric acid or any of the salts of barbituric acid; or (B) a drug which contains any quantity of (i) amphetamine or any of its optical isomers; (ii) any salt of amphetamine or any salt of an optical isomer of amphetamine; or (iii) any substance which the Attorney General, after investigation, has found to be, and by regulation designated as, habit forming because of its stimulant effect on the central nervous system; or (C) lysergic acid diethylamide; or (D) any drug which contains any quantity of a substance which the Attorney General, after investigation, has found to have, and by regulation designated as having, a potential for abuse because of its depressant or stimulant effect on the central nervous system or its hallucinogenic effect. (10) The term “dispense” means to deliver a controlled substance to an ultimate user or research subject by, or pursuant to the lawful order of, a practitioner, including the prescribing and administering of a controlled substance and the packaging, labeling or compounding necessary to prepare the substance for such delivery. The term “dispenser” means a practitioner who so delivers a controlled substance to an ultimate user or research subject. (11) The term “distribute” means to deliver (other than by administering or dispensing) a controlled substance or a listed chemical. The term “distributor” means a person who so delivers a controlled substance or a listed chemical. (12) The term “drug” has the meani...

    79 other bills also change this section · Follow it → Official text at uscode.house.gov ↗

Action History

  1. Presented to President.

  2. Presented to President.

  3. Signed by President.

  4. Signed by President.

  5. Became Public Law No: 118-189.

  6. Became Public Law No: 118-189.

  7. Mr. Bucshon moved to suspend the rules and pass the bill.

  8. Considered under suspension of the rules. (consideration: CR H7166)

  9. DEBATE - The House proceeded with forty minutes of debate on S. 223.

  10. Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H7166)

  11. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H7166)

  12. Motion to reconsider laid on the table Agreed to without objection.

  13. Referred to the Subcommittee on Health.

  14. Received in the House.

  15. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  16. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  17. Message on Senate action sent to the House.

  18. Introduced in Senate

  19. Passed/agreed to in Senate: Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent.(consideration: CR S192; text: CR S192)

  20. Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent. (consideration: CR S192; text: CR S192)

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors S 223?
S 223 is sponsored by Grassley, Chuck (Republican).
What is the current status of S 223?
This bill has been enacted into law. Introduced February 01, 2023. Enacted.
Where can I track S 223?
Track S 223 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 223

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of S 223

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →